Catalyst Wire Dossier Catalyst Wire Dossier

FGF-1

fibroblast growth factor 1 · CardioVascular BioTherapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FGF-1, covering 2019-11-01 to 2019-11-01. Get the full timeline:

Most recent: Clinical Trial Update: FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease [Phase 1, Phase 2]

See pricing